Drax Exametazime (Jubilant DraxImage Inc.)


Welcome to the PulseAid listing for the Drax Exametazime drug offered from Jubilant DraxImage Inc.. This Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Jubilant DraxImage Inc.
NON-PROPRIETARY NAME: Kit for the Preparation of Technetium Tc 99m Exametazime for Leukocyte Labeling
SUBSTANCE NAME: TECHNETIUM TC-99M EXAMETAZIME
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-08-17
END MARKETING DATE: 0000-00-00


Drax Exametazime HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDrax Exametazime from Jubilant DraxImage Inc.
LABELER NAME: Jubilant DraxImage Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.5(mg/1)
START MARKETING DATE: 2017-08-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 65174-200_868165af-d557-453e-8ed4-9cf67e4e7464
PRODUCT NDC: 65174-200
APPLICATION NUMBER: NDA208870

Other TECHNETIUM TC-99M EXAMETAZIME Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Jubilant DraxImage Inc.Drax Exametazime
Medi-Physics Inc. dba GE Healthcare.CERETEC